The Division of Neurology (DN) II regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of Seizures, Epilepsies, Neurological, Medical Countermeasures, Migraine, Other Headaches, Traumatic Brain Injury, Inner Ear Disorders, Multiple Sclerosis, Stroke, Neuroimmunologic Disorders.
Director: Nick Kozauer (Acting)
Deputy Director: TBD
Regulatory Operations Chief, Project Management Staff: Jacqueline Ware, Pharm.D.
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4346
Phone: (301) 796-2250
Fax: (301) 796-9842